Dr Haus Dermatology has introduced a consultant‑led medical weight‑management service, headed by endocrinologist Dr Edson Nogueira. Initial consultations occur in person at its Harley Street clinic, with optional video follow‑ups and home delivery of prescribed treatments. The integrated pathway combines diagnostic testing, personalised prescribing and continuous specialist oversight. The launch responds to rising patient demand for safe, medically supervised weight‑loss solutions amid concerns over unregulated online products.
The UK’s weight‑loss market has shifted from over‑the‑counter supplements to clinically supervised programmes as patients become wary of unregulated online products. Recent surveys show a 30 % increase in demand for medically backed interventions, driven by concerns over safety, efficacy, and long‑term sustainability. Healthcare providers that can combine expertise in metabolism with convenient delivery models are well positioned to capture this growth. In this environment, specialist clinics are expanding beyond their traditional domains to meet broader health‑management needs.
Dr Haus Dermatology’s new service leverages that momentum by offering a consultant‑led weight‑management pathway anchored by endocrinologist Dr Edson Nogueira. Initial assessments are conducted face‑to‑face at the Harley Street clinic, while follow‑up appointments can be delivered through secure video calls, preserving continuity without sacrificing convenience. The model integrates diagnostic testing, personalised prescribing and home delivery of medication, creating a seamless patient journey under continuous specialist oversight. By embedding metabolic expertise within a dermatology practice, the clinic differentiates itself and provides a trusted alternative to fragmented, DIY weight‑loss solutions.
The launch signals a broader trend toward multidisciplinary, evidence‑based clinics that bundle cosmetic, dermatologic and metabolic services under one roof. For investors, such integrated offerings can improve patient retention, increase average revenue per visit, and open new reimbursement pathways as NHS and private insurers look to fund proven weight‑loss programmes. Moreover, the emphasis on clinician‑supervised prescribing addresses regulatory scrutiny and builds consumer confidence, potentially setting a benchmark for other specialty practices. If the service scales, Dr Haus could become a reference model for safe, personalised weight management in the UK.
Comments
Want to join the conversation?